Key result
Systemic administration of human bone marrow-derived and adipose-derived mesenchymal stromal cells ameliorated cardiac damage and reduced the expression of inflammatory markers in mice with polymicrobial sepsis.
Why the study?
Cardiac complications in sepsis independently predict poor outcomes but therapeutic options remain limited, prompting evaluation of the immunomodulatory and cardioprotective effects of mesenchymal stromal cells from different sources.
p-value: p=≤0.05
Human mesenchymal stromal cells from bone marrow and adipose tissue demonstrate cardioprotective and immunomodulatory effects in a mouse model of polymicrobial sepsis.
PURPOSE: Sepsis is a life-threatening condition with cardiac complications being an independent predictor of poor outcome. Although their mechanisms have been widely investigated, therapeutic options remain limited. One promising therapeutic tool are mesenchymal stromal cells (MSCs). The aim of this study is to investigate the immunomodulatory effects of human MSCs from two different sources (bone marrow/BMMSC and adipose tissue/ASC) and to evaluate their cardioprotective potential. METHODS: 60 adult male C57BL/6 mice were divided into sham, sepsis (cecal ligation puncture (CLP)) and two i.v. treatment groups CLP + human BMMSC and CLP + human ASC with 5 animals in each group. The observation periods were 8, 24 and 72 h. Left ventricular tissue was analyzed histologically, by qPCR (C3ar, C5ar1, Il-1b, Il-6, Il-10, Tlr2, Tlr4, Tnfa, and Nlrp3) and western blot. Cardiac damage markers troponin I and heart fatty acid binding protein (HFABP) were detected in serum by ELISA. RESULTS: Troponin I and HFABP were significantly increased in CLP group after 8 h compared to sham. In cardiac tissue the expression of C3ar, C5ar1, Il-1b, Il-6, Il-10, Tlr2, Tlr4, Tnfa and Nlrp3 inflammasome was upregulated up to 24h after CLP compared to sham. After BMMSC treatment, C3ar as well as C5ar, Tlr2 and Il-10 mRNA expression in left ventricle was downregulated compared to CLP, whereas ASC treatment was associated with the downregulation of Il-6 and Nlrp3. CONCLUSIONS: CLP-induced polymicrobial sepsis in mice was associated with cardiac damage and increased inflammation in left ventricular tissue. Therapeutic systemic application of human BMMSC and ASC ameliorated damage and inflammation in the heart.
No takes yet. Share an insight, caveat, or question.
Kanewska et al. (2025) studied Polymicrobial sepsis (n=60). Human bone marrow-derived (BMMSC) and adipose-derived (ASC) mesenchymal stromal cells vs. Sham and CLP + PBS was evaluated on Cardiac damage (Troponin I, HFABP) and inflammatory marker expression in left ventricular tissue (p=≤0.05). Systemic administration of human bone marrow-derived and adipose-derived mesenchymal stromal cells ameliorated cardiac damage and reduced the expression of inflammatory markers in mice with polymicrobial sepsis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: